Literature DB >> 21569214

The Global Online Sexuality Survey (GOSS): erectile dysfunction among Arabic-speaking internet users in the Middle East.

Osama Shaeer1, Kamal Shaeer.   

Abstract

INTRODUCTION: Epidemiologic studies exploring sexuality across different cultures and geographic regions are scanty, particularly from the Middle East. The Global Online Sexuality Survey (GOSS) is an Internet-based survey investigating male and female sexual function. GOSS-Arabic-Males is the Arabic version targeting males in the Middle East, exploring prevalence rate of and factors affecting erectile dysfunction and its therapeutic trends, as well as premature ejaculation, attitudes toward genital size, and contraception. AIM: To explore epidemiologic aspects of male sexuality through an online survey. MAIN OUTCOME MEASURES: Prevalence rate of erectile dysfunction, its relationship to risk factors, and therapeutic trends.
METHODS: The online survey was randomly offered to Web surfers in the Middle East.
RESULTS: Eight hundred four subjects completed the survey. The overall prevalence of ED was 45.1%, strongly correlating with various risk factors studied, including age, diabetes, hypertension under treatment, depression, concerns over genital size, interpersonal distress, premature ejaculation, low libido, and subjective reports of penile deviation. Adjusted to the World Standard Population, the prevalence rate for ED was 47%. Phosphodiesterase (PDE) inhibitors gave a poor response among those with low libido and interpersonal distress, emphasizing the need for proper diagnosis and psychological counseling parallel to medical treatment. Furthermore, PDE inhibitors were stigmatized with unrealistic concerns that decreased their utility to a great extent.
CONCLUSION: In the study population of Arab-speaking Internet users, prevalence of erectile dysfunction and effect of risk factors have proven similar to reports from different parts of the world, though not unanimously. Premature ejaculation, low desire, concerns over penile size, and penile curvature are factors to be considered in the evaluation of ED patients. PDE inhibitors are stigmatized with false beliefs that should be addressed through mass media and counseling if this population is to take full benefit from this therapeutic option.
© 2011 International Society for Sexual Medicine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21569214     DOI: 10.1111/j.1743-6109.2011.02297.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  17 in total

1.  Impact of penile size on male sexual function and role of penile augmentation surgery.

Authors:  Osama Shaeer; Kamal Shaeer
Journal:  Curr Urol Rep       Date:  2012-08       Impact factor: 3.092

Review 2.  Identifying Complementary and Alternative Medicine Usage Information from Internet Resources. A Systematic Review.

Authors:  Vivekanand Sharma; John H Holmes; Indra N Sarkar
Journal:  Methods Inf Med       Date:  2016-06-28       Impact factor: 2.176

3.  Cognitive behavioral therapy as an adjunct treatment for Pakistani men with ED.

Authors:  S Khan; A Amjad; D Rowland
Journal:  Int J Impot Res       Date:  2017-07-13       Impact factor: 2.896

4.  Usefulness of serum fetuin-A level as a marker of erectile dysfunction.

Authors:  W Kandeel; W El-Shaer; A Sebaey; A A Abou-Taleb; A Fathy; B Elmohamady; A I Mansour
Journal:  Int J Impot Res       Date:  2017-04-20       Impact factor: 2.896

5.  Significance of serum endothelial cell specific molecule-1 (Endocan) level in patients with erectile dysfunction: a pilot study.

Authors:  M Karabakan; A Bozkurt; S Akdemir; M Gunay; E Keskin
Journal:  Int J Impot Res       Date:  2017-04-20       Impact factor: 2.896

6.  Sexual habits of men with ED who take phosphodiesterase 5 inhibitors: a survey conducted in 7 countries.

Authors:  John P Mulhall; Tarek A Hassan; James Rienow
Journal:  Int J Clin Pract       Date:  2018-02-20       Impact factor: 2.503

7.  Erectile dysfunction in qatar: prevalence and risk factors in 1,052 participants-a pilot study.

Authors:  Abdulla Al Naimi; Ahmad A Majzoub; Raidh A Talib; Onder Canguven; Abdulla Al Ansari
Journal:  Sex Med       Date:  2014-06       Impact factor: 2.491

Review 8.  Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: Current information and new horizons.

Authors:  James E Ferguson; Culley C Carson
Journal:  Arab J Urol       Date:  2013-09-18

Review 9.  Erectile dysfunction in Arab countries. Part I: Prevalence and correlates.

Authors:  Ahmed I El-Sakka
Journal:  Arab J Urol       Date:  2012-02-28

Review 10.  Sexual dysfunction in 2013: Advances in epidemiology, diagnosis and treatment.

Authors:  King Chien Joe Lee; Nader Fahmy; Gerald B Brock
Journal:  Arab J Urol       Date:  2013-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.